These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 17899293)

  • 21. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
    Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ratios of involved nodes in early breast cancer.
    Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M
    Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of axillary lymph node involvement in women with T3 breast cancers: analysis of 1988-2003 SEER data.
    Fields RC; Jeffe DB; Deshpande AD; Feunou F; Krishna N; Margenthaler JA
    J Surg Res; 2010 Jun; 161(2):183-9. PubMed ID: 19959188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of axillary lymphadenectomy on breast carcinoma survival.
    Joslyn SA; Konety BR
    Breast Cancer Res Treat; 2005 May; 91(1):11-8. PubMed ID: 15868427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD; Chen SL; Schneider PD; Martinez SR
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
    Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
    Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast.
    Taras AR; Hendrickson NA; Pugliese MS; Lowe KA; Atwood M; Beatty JD
    Am J Surg; 2009 May; 197(5):643-6; discussion 646-7. PubMed ID: 19393357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on prognosis in breast cancer patients with extensive axillary disease.
    Hoehne F; Chen S; Mabry H; Giuliano AE
    Breast J; 2008; 14(1):76-80. PubMed ID: 18086270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
    Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
    Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node?
    Guth AA; Mercado C; Roses DF; Hiotis K; Skinner K; Diflo T; Cangiarella J
    Am J Surg; 2006 Oct; 192(4):502-5. PubMed ID: 16978960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer.
    Neri A; Marrelli D; Roviello F; De Stefano A; Guarnieri A; Pallucca E; Pinto E
    Ann Surg Oncol; 2005 Mar; 12(3):246-53. PubMed ID: 15827817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
    J Clin Oncol; 2010 Jun; 28(17):2868-73. PubMed ID: 20458033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular dyscohesion in fine-needle aspiration of breast carcinoma. Prognostic indicator for axillary lymph node metastases?
    Schiller AB; Tadros TS; Birdsong GG; Grossl NA
    Am J Clin Pathol; 2001 Feb; 115(2):219-23. PubMed ID: 11211610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
    Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
    Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.